| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 2865162-09-8 | Benzyl (S)-4-(5-(5-bromo-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-1H-indol-2-YL)-6-(1-methoxyethyl)pyridin-3-YL)piperazine-1-carboxylate;benzyl 4-(5-(5-bromo-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)indol-2-yl)-6-((1S)-1-methoxyethyl)pyridin-3-yl)piperazine-1-carboxylate | C35H43BrN4O4 |
| 2869954-34-5 | Werner syndrome RecQ helicase-IN-1;HRO761; N-(2-chloro-4-(trifluoromethyl)phenyl)-2-(2-(3,6-dihydro-2H-pyran-4-yl)-5-ethyl-6-(4-(5-hydroxy-6-methylpyrimidine-4-carbonyl)piperazin-1-yl)-7-oxo-(1,2,4)triazolo(1,5-a)pyrimidin-4-yl)acetamide | C31H31ClF3N9O5 |
| 2875067-31-3 | (R)-4,4,4-Trifluoro-3-hydroxy-3-methylbutan-2-one;(3R)-4,4,4-trifluoro-3-hydroxy-3-methylbutan-2-one | C5H7F3O2 |
| 2915356-76-0 | Fmoc-L-Lys(C20-OtBu-Glu(OtBu)-AEEA-AEEA)-OH;Tirzepatide sidechain | C66H105N5O16 |
| 2922526-56-3 | (4-(3,6-Dimethoxy-9h-carbazol-9-yl)butyl)phosphonic acid;MeO-4PACz | C18H22NO5P |
| 2922732-54-3 | RMC-9805;KRAS G12D inhibitor 18; (2S)-2-cyclopentyl-2-((5S)-2-((2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl)-2,7-diazaspiro(4.4)nonan-7-yl)-N-((6S,8S,14S)-21-(5-(4-cyclopropylpiperazin-1-yl)-2-((1S)-1-methoxyethyl)pyridin-3-yl)-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo(18.5.2.12,6.110,14.023,27)nonacosa-1(26),20,23(27),24-tetraen-8-yl)acetamide | C63H88F3N11O7 |
| 2937344-16-4 | BI-2493;KRAS INHIBITOR; (7S)-2'-amino-3-(2-((2S)-2-methylpiperazin-1-yl)pyrimidin-4-yl)spiro(5,6-dihydro-4H-1,2-benzoxazole-7,4'-6,7-dihydro-5H-1-benzothiophene)-3'-carbonitrile; (S)-2-amino-3'-(2-((S)-2-methylpiperazin-1-yl)pyrimidin-4-yl)-5',6,6',7-tetrahydro-4'H,5H-spiro(benzo(b)thiophene-4,7'-benzo(d)isoxazole)-3-carbonitrile | C24H27N7OS |
| 2971088-37-4 | (4-(2,7-Dibromo-9,9-dimethylacridin-10(9H)-yl)butyl)phosphonic acid | C19H22Br2NO3P |